Posted by Michael Wonder on 24 Jul 2025
Lilly to launch Mounjaro in Korea in August without reimbursement
23 July 2025 - Eli Lilly Korea is moving forward with the launch of its blockbuster Mounjaro (tirzepatide) next month, even as pricing negotiations with Government remain incomplete.
The company said Tuesday it will begin supplying 2.5 mg and 5mg doses of the once-weekly pre-filled pen for type 2 diabetes and obesity in mid-August.
